Raymond James Financial Inc Inmune Bio, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 382,041 shares of INMB stock, worth $855,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
382,041
Previous 475,551
19.66%
Holding current value
$855,771
Previous $2.22 Million
34.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INMB
# of Institutions
90Shares Held
6.83MCall Options Held
202KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$1.94 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$1.85 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.82 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.34 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$827,5410.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $40.2M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...